细胞清洗机市场 - 副产品（设备 [自动、手动]、消耗品 [一次性、可重复使用]）、最终用途（诊断实验室、血库、输血中心） - 全球预测 (2024 - 2032)

Cell Washers Market - By Product (Equipment [Automated, Manual], Consumables [Single-use, Reusable]), End-use (Diagnostic Labs, Blood Banks, Transfusion Centers) - Global Forecast (2024 - 2032)

出版日期: 2024年05月07日 | 出版商:

Global Market Insights Inc. | 英文 154 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在慢性病盛行率上升的推动下，细胞清洗机市场规模在 2024 年至 2032 年期间将呈现 4.8% 的复合年增长率。据世界卫生组织称，每年，癌症、糖尿病和心血管疾病等非传染性疾病总共导致全球约 3,600 万人死亡。细胞清洗机透过确保疾病诊断、药物开发和个人化治疗方法中使用的细胞样本的纯度和活力，在生物医学研究和临床诊断中发挥着至关重要的作用。医疗保健提供者越来越强调需要精确、高效的细胞清洗技术，以加强疾病管理并提高患者的治疗效果，从而塑造市场前景。

在人们日益重视预防性和个人化医疗保健的推动下，配备最先进生物医学技术的新医院、诊所和研究中心的建立，将进一步增加未来几年的产品需求。

细胞清洗机产业根据产品、最终用途和地区进行分类。

到 2032 年，自动化细胞清洗设备领域将快速成长，因为这些先进的系统提高了工作流程效率并确保结果一致。自动化细胞清洗机不仅可以减少人工错误，还可以优化实验室和临床环境中的时间和资源利用率。这项技术飞跃强调了对提高营运效率和维持高标准的研究完整性的承诺，有利于更广泛的产品采用。

到 2032 年，血库领域将变得更加突出，因为这些设施依靠细胞清洗机来确保输血和治疗中使用的血液成分的纯度和活力。血液製品严格的监管标准需要可靠的细胞清洗系统，以有效去除污染物并确保产品安全。随着血库扩大产能以满足不断增长的医疗保健需求，先进细胞清洗机的采用预计将大幅增加。

在强大的医疗基础设施和广泛的研究活动的推动下，到 2032 年，欧洲细胞清洗机产业规模将快速成长。德国、法国和英国等国家正在生物技术和医疗保健领域进行大量投资，从而刺激了对创新细胞清洗解决方案的需求。该地区积极主动的医疗现代化和卓越研究继续为市场参与者创造利润丰厚的机会。此外，严格的监管框架确保欧洲医疗机构部署的细胞清洗机的高品质和可靠性，进一步促进产业成长。

产业生态系统分析
产业影响力
- 成长动力
  - 慢性病负担日益加重
  - 输血需求增加
  - 细胞清洗技术的进步
- 产业陷阱与挑战
  - 设备成本高
  - 欠发达国家的医疗保健设施有限
成长潜力分析
技术景观
监管环境
2023 年定价分析
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
战略展望矩阵

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
装置
- 自动化
- 手动的
耗材
- 一次使用
- 可重复使用的

第 6 章：市场估计与预测：依最终用途，2021 - 2032 年

主要趋势
诊断实验室
血库和输血中心
其他最终用户

第 7 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 8 章：公司简介

Andreas Hettich GmbH & Co. KG
Bio-Rad Laboratories, Inc.
Centurion Scientific
Changsha Yingtai Instrument Co., Ltd.
Corning Incorporated
CYTENA GmbH
Danaher Corporation
Fresenius SE & Co. KGaA
Haemonetics Corporation
Helmer Scientific Inc.
Labtron Equipment Ltd.
LivaNova PLC
Labozon Scientific Inc.
Medfuture Biotech Co., Ltd.
Terumo Corporation

简介目录

Product Code: 9399

The Cell Washers Market size will exhibit a 4.8% CAGR during 2024-2032, driven by the rising prevalence of chronic diseases. According to the WHO, every year, non-communicable diseases such as cancer, diabetes, and cardiovascular ailments collectively contribute to an estimated 36 million deaths globally. Cell washers play a crucial role in biomedical research and clinical diagnostics by ensuring the purity and viability of cellular samples used in disease diagnosis, drug development, and personalized treatment approaches. Healthcare providers are increasingly emphasizing the need for precise and efficient cell washing technologies to bolster disease management and elevate patient outcomes, shaping the market outlook.

The establishment of new hospitals, clinics, and research centers equipped with state-of-the-art biomedical technologies, driven by the growing emphasis on preventive and personalized healthcare, will further augment the product demand in the coming years.

The cell washers industry is classified based on product, end-use, and region.

The automated cell washers equipment segment will grow rapidly through 2032, as these advanced systems enhance workflow efficiency and ensure consistent results. Automated cell washers not only reduce manual errors but also optimize time and resource utilization in laboratories and clinical settings. This technological leap underscores the commitment to enhancing operational efficiencies and maintaining high standards of research integrity, favoring wider product adoption.

The blood banks segment will gain prominence through 2032, as these facilities rely on cell washers to ensure the purity and viability of blood components used in transfusions and therapies. The stringent regulatory standards governing blood products necessitate reliable cell washing systems that can effectively remove contaminants and ensure product safety. As blood banks expand their capacities to meet growing healthcare demands, the adoption of advanced cell washers is poised to increase significantly.

Europe cell washers industry size will grow at a fast pace through 2032, driven by robust healthcare infrastructure and extensive research activities. Countries such as Germany, France, and the UK are witnessing substantial investments in biotechnology and healthcare, thereby fueling the demand for innovative cell washing solutions. The region's proactive approach to healthcare modernization and research excellence continues to create lucrative opportunities for market players. Additionally, stringent regulatory frameworks ensure the high quality and reliability of cell washers deployed across European healthcare facilities, further bolstering industry growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing burden of chronic diseases
  - 3.2.1.2 Rising demand for blood transfusion
  - 3.2.1.3 Advancements in cell washer technology
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of equipment
  - 3.2.2.2 Limited access to healthcare facilities in underdeveloped countries
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Pricing analysis, 2023
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn, Units)

5.1 Key trends
5.2 Equipment
- 5.2.1 Automated
- 5.2.2 Manual
5.3 Consumables
- 5.3.1 Single-use
- 5.3.2 Reusable

Chapter 6 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Diagnostic laboratories
6.3 Blood banks and transfusion centers
6.4 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn, Units)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa